Atlas Trials

Sirolimus in Combination With MEC in High Risk Myeloid Leukemias

Clinical trial NCT00780104 · COMPLETED

Trial details

NCT number
NCT00780104
Sponsor
Abramson Cancer Center at Penn Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Myeloid LeukemiasAMLLeukemiaCML
Start date
2007-07-01
Primary completion
2010-01-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.